Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors

Linda Y. Wu; Grace van Hyfte; Umut Özbek; Marlene Reincke; Anuhya Gampa; Yehia I. Mohamed; Naoshi Nishida; Brooke Wietharn; Suneetha Amara; Pei‐Chang Lee; Bernhard Scheiner; Lorenz Balcar; Matthias Pinter; Arndt Vogel; Arndt Weinmann; Anwaar Saeed; Anjana Pillai; Lorenza Rimassa; Abdul Rafeh Naqash; Mahvish Muzaffar; Yi‐Hsiang Huang; Ahmed O. Kaseb; Masatoshi Kudo; David J. Pinato; Celina Ang

doi:10.3389/fonc.2023.1128569

Related publications

Article2025

Real-world outcomes of immunosuppressed patients with Merkel cell carcinoma treated with immune checkpoint inhibitors.

William Mullally, Andrew S. Brohl, Aisha Ghaus, Mark Shackleton, Yang Wang, Shahneen Sandhu, Jürgen Becker, Marcin Dzienis, Liam Dwyer, Jenny Lee, Adnan Khattak, Lydia Warburton, Christopher Steer, Wen Xu

Article2024

Initial uptake of durvalumab with or without tremelimumab for advanced hepatocellular carcinoma in routine clinical practice: Preliminary results of the international DT-real study.

Ciro Celsa, Naoshi Nishida, Ashwini Arvind, Susanna V. Ulahannan, Michael Li, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Giulia Francesca Manfredi, Bernardo Stefanini, Giuseppe Cabibbo, Alessio Cortellini, Matthias Pinter, Robin Kate Kelley, Paul Antoine El Tomb, Amit G. Singal, Masatoshi Kudo, David J. Pinato

Article2018

KEYNOTE-224: Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.

Andrew X. Zhu, Richard S. Finn, Stéphane Cattan, Julien Edeline, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Olivier Rosmorduc, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Scot Ebbinghaus, Junshui Ma, Abby B. Siegel, Ann‐Lii Cheng, Masatoshi Kudo

Article2022

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Linda Y. Wu, Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi‐Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominik Bettinger, Arndt Vogel, Martin Schönlein,

Dataset

Supplementary Material for: Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab

M. Rimini, M. Persano, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Jaekyung Cheon, F. Finkelmeier, Lim H.Y., J. PresaRamos, Gianluca Masi, Yoo C., S. Lonardi, Bernardo Stefanini, Takashi Kumada, Naomi Sakamoto, Hideki Iwamoto, Tomoko Aoki, Chon H.J., Vera Himmelsbach, Melania Montes, Caterina Vivaldi, ,